Griffin Asset Management, Inc. Astrazeneca PLC Transaction History

Griffin Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 27, 2021	SELL	$48.52 - $58.02 $449,343 - $537,323	-9,261 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $7,058 - $8,126	133 Added 1.46%	9,261 $508,000
Q2 2020 Aug 18, 2020	BUY	$43.1 - $55.31 $86,200 - $110,620	2,000 Added 28.06%	9,128 $483,000
Q1 2020 May 18, 2020	SELL	$37.79 - $51.33 $1,700 - $2,309	-45 Reduced 0.63%	7,128 $318,000
Q3 2019 Nov 05, 2019	SELL	$40.12 - $45.47 $19,618 - $22,234	-489 Reduced 6.38%	7,173 $320,000
Q2 2019 Aug 19, 2019	SELL	$37.28 - $41.68 $91,820 - $102,657	-2,463 Reduced 24.33%	7,662 $316,000
Q1 2019 May 08, 2019	SELL	$35.49 - $43.02 $106,470 - $129,060	-3,000 Reduced 22.86%	10,125 $409,000
Q3 2018 Nov 19, 2018	BUY	$34.76 - $39.72 $456,225 - $521,325	13,125 New	13,125 $519,000

1,367

475M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Griffin Asset Management, Inc. with notifications on news.